AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Akari Therapeutics Plc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$9.89+1.71 (+20.90%)
Close on Oct 19, 2026
- Market cap
- $1.42T
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Akari Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Proxy statement | DEF 14A | Oct 1, 2026 | Oct 1, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2026 | Oct 1, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jul 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2026 | Jun 26, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 4, 2026 | Jun 4, 2026 | SEC EDGAR |
| Current report | 8-K | May 20, 2026 | May 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 19, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2026 | Mar 17, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 2, 2026 | Mar 2, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Feb 2, 2026 | Feb 2, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2025 | Dec 17, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 15, 2025 | Dec 16, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 8, 2025 | Dec 8, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 24, 2025 | Nov 26, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Nov 17, 2025 | Nov 17, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 22, 2025 | Oct 23, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2025 | Oct 16, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2025 | Oct 15, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2025 | Sep 29, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 19, 2025 | Sep 25, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 28, 2025 | Aug 29, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 15, 2025 | Aug 21, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2025 | Aug 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jul 1, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 6, 2025 | Jun 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 16, 2025 | Apr 16, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Apr 15, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 14, 2025 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 2, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2024 | Dec 18, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2024 | Dec 16, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 6, 2024 | Dec 12, 2024 | SEC EDGAR |